BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7466413)

  • 21. [Use of aminoglutethimide in the hormonal treatment of patients with advanced breast cancer].
    Wojtacki J; Dziewulska-Bokiniec A; Czech I
    Ginekol Pol; 1994 Sep; 65(9):508-11. PubMed ID: 7721164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
    Morris KT; Toth-Fejel S; Schmidt J; Fletcher WS; Pommier RF
    Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of residual oestrogen production with aminoglutethimide in women following surgical hypophysectomy or adrenalectomy.
    Samojlik E; Santen RJ; Worgul TJ
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):43-51. PubMed ID: 6692582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Isotopic scanning in the diagnosis of bone metastases of breast cancer. Comparative study with radiologic and clinical observations].
    Duque Gallo JJ; Yarza JC; Ros L; Borau MJ; Ramírez R; Baringo T; Ascaso A; Navarro Izquierdo AL
    Rev Esp Oncol; 1983; 30(2):199-207. PubMed ID: 6097964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies in patients with metastatic breast carcinoma treated with aminoglutethimide for medical adrenalectomy.
    Wells SA; Haagensen DE; Misbin R; Lipton A; Smart E; Santen RJ
    Surg Forum; 1976; 27(62):101-2. PubMed ID: 1019817
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of surgical adrenalectomy to medical adrenalectomy in patients with metastatic carcinoma of the breast.
    Wells SA; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H; White D; Smart E; Cox C; Santen RJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3454s-3457s. PubMed ID: 7044527
    [No Abstract]   [Full Text] [Related]  

  • 27. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
    Smith IE; Harris AL; Morgan M; Ford HT; Gazet JC; Harmer CL; White H; Parsons CA; Villardo A; Walsh G; McKinna JA
    Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1432-4. PubMed ID: 6797571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ
    Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoglutethimide in patients with metastatic breast cancer.
    Nemoto T; Rosner D; Patel JK; Dao TL
    Cancer; 1989 May; 63(9):1673-5. PubMed ID: 2467735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metastatic bone disease. Strategies for imaging].
    Scutellari PN; Antinolfi G; Galeotti R; Giganti M
    Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
    Santen RJ; Worgul TJ; Samojlik E; Interrante A; Boucher AE; Lipton A; Harvey HA; White DS; Smart E; Cox C; Wells SA
    N Engl J Med; 1981 Sep; 305(10):545-51. PubMed ID: 7019703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer].
    Schmidt UM; Brockmann B; Geschke E
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
    Holdaway IM
    Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aminoglutethimide in metastasizing carcinoma of the breast resistant to hormonal and cytostatic treatment (author's transl)].
    Rieche K
    Dtsch Med Wochenschr; 1981 Oct; 106(40):1296-300. PubMed ID: 7274074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semilunar osteoblastic metastases in breast carcinoma. A new radiological sign.
    Cochrane LB; Heselson NG; Freson M
    J Belge Radiol; 1989 Dec; 72(6):497-500. PubMed ID: 2559915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma.
    Worgul TJ; Santen RJ; Samojlik E; Veldhuis JD; Lipton A; Harvey HA; Drago JR; Rohner TJ
    J Urol; 1983 Jan; 129(1):51-5. PubMed ID: 6827685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglutethimide in treatment of metastatic breast carcinoma.
    Smith IE; Fitzharris BM; McKinna JA; Fahmy DR; Nash AG; Neville AM; Gazet JC; Ford HT; Powles TJ
    Lancet; 1978 Sep; 2(8091):646-9. PubMed ID: 80576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Palliative treatment of skeletal metastases in patients with breast carcinoma].
    van der Werken C; Dolman A; Maat B
    Ned Tijdschr Geneeskd; 1987 Apr; 131(15):609-12. PubMed ID: 2437463
    [No Abstract]   [Full Text] [Related]  

  • 39. Aminoglutethimide therapy in advanced breast cancer.
    Anderson JL; Phillipou G; Black RB
    Aust N Z J Surg; 1981 Feb; 51(1):20-2. PubMed ID: 7013749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglutethimide vs. surgical adrenalectomy in breast cancer.
    N Engl J Med; 1982 Jan; 306(1):44-6. PubMed ID: 7053472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.